Does Ozempic actually cause your teeth to fall out?

What did @kendberrymd actually say?

Ken Berry, MD, stopped short of saying Ozempic directly damages teeth. His actual claim was softer but still alarming: he said it "would not surprise" him if GLP-1 users experienced gum recession, loose teeth, or even tooth loss, because most people on these drugs keep eating "nutrient void" food. He's not blaming the drug itself. He's blaming the diet that persists alongside it.

That framing matters. He's essentially arguing that GLP-1-induced appetite suppression, when combined with a poor-quality diet, could reduce the intake of nutrients needed to maintain gum and bone health. It's a speculative chain of reasoning, not a direct pharmacological claim. But speculative reasoning delivered in an authoritative tone on TikTok tends to land as established fact, and that's where this gets problematic.

Does the science back this up?

Weakly, and mostly indirectly. There is no strong clinical evidence that semaglutide or other GLP-1 agonists cause gum recession or tooth loss as a direct pharmacological effect. The FDA's adverse event reporting system and the clinical trial data for Ozempic and Wegovy do not list periodontitis or tooth loss as identified risks.

What does exist is a well-documented connection between malnutrition and periodontal disease. Deficiencies in vitamin C, vitamin D, calcium, and zinc are all associated with impaired gum tissue integrity and alveolar bone loss (Van der Velden et al., 2011, Journal of Clinical Periodontology). Separately, GLP-1 drugs do suppress appetite significantly, and there is legitimate concern in the nutrition literature that caloric restriction on these drugs, without dietary guidance, can lead to inadequate micronutrient intake. A 2023 analysis in Obesity Reviews (Lim et al.) noted that patients on semaglutide who did not receive dietary counseling showed reduced intake of several key micronutrients. But connecting that to actual tooth loss in a clinical population? That evidence doesn't exist yet.

What did they get wrong (or right)?

Berry gets partial credit for identifying a real and underappreciated clinical gap: GLP-1 prescribing often happens without nutritional support, and that matters. Patients eating less but not eating better is a legitimate concern, and practitioners who prescribe these medications without dietary follow-up are doing their patients a disservice.

Where he goes wrong is the leap from "nutrient-poor diet" to "teeth falling out" without any population-level data connecting GLP-1 use to periodontal outcomes. Framing severe tooth loss as an unsurprising outcome of Ozempic use, even indirectly, is a significant overreach. It feeds into unfounded fear about a drug class that has demonstrated cardiovascular and metabolic benefits in large trials like the SELECT trial (Lincoff et al., 2023, NEJM). Speculative worst-case scenarios, dressed up as clinical intuition, can discourage people from using medications that might genuinely help them.

There's also a problem with the underlying logic. The "Standard American Diet" is already nutrient poor before someone starts Ozempic. If it caused widespread tooth loss on its own, we'd see that signal clearly in the general population independent of GLP-1 use. We don't.

What should you actually know?

If you're on a GLP-1 medication and eating significantly less, micronutrient intake is worth paying attention to. This is not a new concern, it applies to any sustained caloric restriction, including bariatric surgery patients who are routinely monitored for deficiencies. Protein intake in particular tends to drop on GLP-1 drugs, and inadequate protein affects soft tissue repair throughout the body, including gum tissue.

The practical steps are straightforward: work with a registered dietitian if you're on a GLP-1 drug, prioritize nutrient-dense foods within your reduced appetite window, and keep up with dental cleanings. If you notice gum sensitivity or changes in your mouth, tell your dentist you're on a GLP-1 agonist so they can monitor appropriately. None of this requires accepting the premise that your teeth are at imminent risk of falling out because you took Wegovy.

The broader issue is that "I wouldn't be surprised if" is not a medical finding. It's a prior. And when doctors present their priors on social media without distinguishing them from evidence, audiences can't tell the difference.